ArticleEuropean journal of pharmacology2018

In vitro and in vivo functional profile characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3-carboxamido)morphinan (NAQ) as a low efficacy mu opioid receptor modulator.

Samuel Obeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.